Friday, 22 December 2017

Ocular Therapeutix gets subpoena from SEC over eye pain drug

(Reuters) - Ocular Therapeutix Inc said on Friday the U.S. Securities and Exchange Commission (SEC) had issued a subpoena seeking information about the company's eye-pain drug Dextenza.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)